IQVIA艾昆纬：2023年全球研发趋势报告（英文版）

As the global healthcare system re-equilibrates post-pandemic, the biopharmaceutical industry has resumed pre-COVID-19 levels of investment, pipeline activity, and launch of novel medicines following record breaking levels of each in 2020 and 2021. Process and technology innovations that were accelerated by extreme circumstances during the pandemic are being integrated across the global pipeline and implemented as operational and organizational changes that are enabling ongoing productivity g